(Q48760641)

15 February 2018

title

Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. (English)

1 reference

15 February 2018

Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics

sponsor

0 references

main subject

nanoparticle

0 references

author

Lucienne Juillerat-Jeanneret

4

object named as

Lucienne Juillerat-Jeanneret

1 reference

15 February 2018

author name string

Blanka Halamoda Kenzaoui

1

1 reference

15 February 2018

Catherine Chapuis Bernasconi

2

1 reference

15 February 2018

Heinrich Hofmann

3

1 reference

15 February 2018

publication date

1 January 2012

1 reference

15 February 2018

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

Nanomedicine

1 reference

15 February 2018

volume

7

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

39-53

1 reference

15 February 2018

The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?

cites work

1 reference

Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review

21 January 2018

1 reference

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

21 January 2018

1 reference

Effect of surface properties on nanoparticle-cell interactions

21 January 2018

1 reference

Nanocarriers' entry into the cell: relevance to drug delivery

21 January 2018

1 reference

Toxic potential of materials at the nanolevel

21 January 2018

1 reference

Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm

21 January 2018

1 reference

Role of oxidative damage in toxicity of particulates

21 January 2018

1 reference

Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress

21 January 2018

1 reference

Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells

21 January 2018

1 reference

Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.

21 January 2018

1 reference

Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs

21 January 2018

1 reference

Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin

21 January 2018

1 reference

Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.

21 January 2018

1 reference

Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field

21 January 2018

1 reference

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.

21 January 2018

1 reference

Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier

21 January 2018

1 reference

A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.

21 January 2018

1 reference

Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.

21 January 2018

1 reference

Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.

21 January 2018

1 reference

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

21 January 2018

1 reference

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

21 January 2018

1 reference

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.

21 January 2018

1 reference

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

21 January 2018

1 reference

Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

21 January 2018

1 reference

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.

21 January 2018

1 reference

The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain

21 January 2018

1 reference

Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier

21 January 2018

1 reference

The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.

21 January 2018

1 reference

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.

21 January 2018

1 reference

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters

21 January 2018

1 reference

Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles

21 January 2018

1 reference

Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling

21 January 2018

1 reference

Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling.

21 January 2018

1 reference

Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier

21 January 2018

1 reference

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

21 January 2018

1 reference

Nanoparticulate transport of oximes over an in vitro blood-brain barrier model

21 January 2018

1 reference

Interaction of cationic ultrasmall superparamagnetic iron oxide nanoparticles with human melanoma cells

21 January 2018

1 reference

Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site

21 January 2018

1 reference

Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis.

21 January 2018

1 reference

Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain

21 January 2018

1 reference

Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.

21 January 2018

1 reference

Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.11.85

1 reference

15 February 2018

release_pq6fyvsfg5cbpicla3yy7lxgo4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pq6fyvsfg5cbpicla3yy7lxgo4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22191777

1 reference

15 February 2018